educed Risk of Restenosis in Small Vessels and educed Risk of Myocardial Infarction in Long Lesions ith the New Thin-Strut TAXUS Liberté Stent-Year Results From the TAXUS ATLAS Program ark

bjectives The TAXUS ATLAS Small Vessel (SV) and Long Lesion (LL) multicenter studies compared he performance of the thin-strut (0.0038 inch) TAXUS Liberté 2.25-mm stent (Boston Scientific; atick, Massachusetts) and the TAXUS Liberté 38-mm long stent (Boston Scientific; Natick, Massahusetts) with the earlier paclitaxel-eluting TAXUS Express (Boston Scientific) stent that has identical olymer, drug dosage, and release kinetics but different stent geometry and thicker struts (0.0052 nch).